Concepts and challenges of biosimilars to mitigate the oncology drug expenses
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
| Yazar: | |
|---|---|
| Diğer Yazarlar: | |
| Materyal Türü: | Tez |
| Dil: | en_US |
| Baskı/Yayın Bilgisi: |
Brac University
2021
|
| Konular: | |
| Online Erişim: | http://hdl.handle.net/10361/15111 |
| id |
10361-15111 |
|---|---|
| record_format |
dspace |
| spelling |
10361-151112021-10-03T21:01:41Z Concepts and challenges of biosimilars to mitigate the oncology drug expenses Tania, Umme Haque , Md. Aminul Department of Pharmacy, Brac University Biosimilars Interchangeability Cancer therapy Monoclonal antibodies Biologic medicines Comparability exercise This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. Cataloged from PDF version of thesis report. Includes bibliographical references (pages 38-48). Biosimilars is way more likely to genuine generic drugs of the innovator. Time to time expiry of generic drugs helps manufacturer to think about biosimilars which has wide cost effectiveness as well as expanded patient accessibility to medicines especially for malignancy patients. This article gives a refreshed audit of the biosimilar pharmaceutical products affirmed for disease treatment in the US and EU through strict pre-clinical, clinical as well as pharmacovigilance touchstones. Diverse oncological biosimilar drugs that are right now being utilized like epoetins (alpha and zeta), filgrastim, as well as mAb (rituximab, trastuzumab and bevacizumab) are being exhibited in this article. Umme Tania B. Pharmacy 2021-10-03T09:01:45Z 2021-10-03T09:01:45Z 2021. 2021-02 Thesis ID: 16346032 http://hdl.handle.net/10361/15111 en_US Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 51 Pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
en_US |
| topic |
Biosimilars Interchangeability Cancer therapy Monoclonal antibodies Biologic medicines Comparability exercise |
| spellingShingle |
Biosimilars Interchangeability Cancer therapy Monoclonal antibodies Biologic medicines Comparability exercise Tania, Umme Concepts and challenges of biosimilars to mitigate the oncology drug expenses |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. |
| author2 |
Haque , Md. Aminul |
| author_facet |
Haque , Md. Aminul Tania, Umme |
| format |
Thesis |
| author |
Tania, Umme |
| author_sort |
Tania, Umme |
| title |
Concepts and challenges of biosimilars to mitigate the oncology drug expenses |
| title_short |
Concepts and challenges of biosimilars to mitigate the oncology drug expenses |
| title_full |
Concepts and challenges of biosimilars to mitigate the oncology drug expenses |
| title_fullStr |
Concepts and challenges of biosimilars to mitigate the oncology drug expenses |
| title_full_unstemmed |
Concepts and challenges of biosimilars to mitigate the oncology drug expenses |
| title_sort |
concepts and challenges of biosimilars to mitigate the oncology drug expenses |
| publisher |
Brac University |
| publishDate |
2021 |
| url |
http://hdl.handle.net/10361/15111 |
| work_keys_str_mv |
AT taniaumme conceptsandchallengesofbiosimilarstomitigatetheoncologydrugexpenses |
| _version_ |
1814307560054849536 |